TerminatedPhase 3

Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.

Stopped: Halted prematurely due to low recruitment rate.

Spain81 participantsStarted 2014-05-21

Plain-language summary

The main objective of this trial is to study the occurrence of preeclampsia in recipients of donated oocytes receiving aspirin at an early stage during pregnancy and to compare the results with those obtained in patients receiving placebo.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years. * Recipients of donated oocytes. * Pregnant women. * Single or twin gestations. * Patients who accept the conditions of the study by signing the appropriate informed consent. Exclusion Criteria: * Known allergy to acetylsalicylic acid . * Personal history of peptic ulcer. * Triplets. * Use of prostaglandin inhibitors within 10 days prior to baseline. * Personal history of chronic kidney, thyroid, liver or heart disease. * Psychiatric or cognitive pathology that prevents understanding of the conditions of informed consent.

What they're measuring

Occurrence of preeclampsia.

Timeframe: Up to 42 weeks

Trial details

NCT IDNCT02174328

SponsorInstituto de Investigacion Sanitaria La Fe

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04-20

View on ClinicalTrials.gov More Pre-Eclampsia trials